Immutep Ltd. (IMMP)
Immutep Market Cap
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 27, 2026 | 63.26M |
| May 26, 2026 | 66.04M |
| May 22, 2026 | 70.73M |
| May 21, 2026 | 69.91M |
| May 20, 2026 | 68.14M |
| May 19, 2026 | 73.20M |
| May 18, 2026 | 71.91M |
| May 15, 2026 | 75.65M |
| May 14, 2026 | 65.71M |
| May 13, 2026 | 67.52M |
| May 12, 2026 | 68.44M |
| May 11, 2026 | 64.50M |
| May 08, 2026 | 64.92M |
| May 07, 2026 | 62.94M |
| May 06, 2026 | 64.40M |
| May 05, 2026 | 66.90M |
| May 04, 2026 | 67.13M |
| May 01, 2026 | 63.49M |
| April 30, 2026 | 67.29M |
| April 29, 2026 | 69.52M |
| April 28, 2026 | 70.95M |
| April 27, 2026 | 76.35M |
| April 24, 2026 | 83.41M |
| April 23, 2026 | 83.10M |
| April 22, 2026 | 86.24M |
| Date | Value |
|---|---|
| April 21, 2026 | 85.89M |
| April 20, 2026 | 89.75M |
| April 17, 2026 | 85.01M |
| April 16, 2026 | 84.37M |
| April 15, 2026 | 79.18M |
| April 14, 2026 | 45.82M |
| April 13, 2026 | 44.86M |
| April 10, 2026 | 45.57M |
| April 09, 2026 | 46.75M |
| April 08, 2026 | 51.32M |
| April 07, 2026 | 51.75M |
| April 06, 2026 | 52.40M |
| April 02, 2026 | 52.62M |
| April 01, 2026 | 53.86M |
| March 31, 2026 | 51.09M |
| March 30, 2026 | 50.95M |
| March 27, 2026 | 51.31M |
| March 26, 2026 | 52.42M |
| March 25, 2026 | 53.57M |
| March 24, 2026 | 52.55M |
| March 23, 2026 | 56.07M |
| March 20, 2026 | 57.45M |
| March 19, 2026 | 60.06M |
| March 18, 2026 | 60.48M |
| March 17, 2026 | 58.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Mesoblast Ltd. | 1.186B |
| CSL Ltd. | -- |
| Opthea Ltd. | -- |
| Propanc Biopharma, Inc. | 1.233M |
| Actinogen Medical Ltd. | -- |
Market Cap Related Metrics
| PS Ratio | 19.60 |
| PEG Ratio | -0.0220 |
| Price | 0.3579 |
| Earnings Yield | -103.4% |
| PEGY Ratio | -0.0220 |